Sodium (4aR,6R,7R,7aR)-6-[6-(butyrylamino)-9H-purin-9-yl]-7-(butyryloxy)tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-2-olate 2-oxide(CAS: 16980-89-5)

Sodium (4aR,6R,7R,7aR)-6-[6-(butyrylamino)-9H-purin-9-yl]-7-(butyryloxy)tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-2-olate 2-oxide (CAS: 16980-89-5) is a complex organic compound with a unique structure containing a purine ring and a dioxaphosphinine ring. It exhibits specific chemical properties and is often used in specialized chemical applications. Its molecular formula is C17H25N5O10PNa, and it is typically characterized by its solubility in polar solvents and stability under controlled conditions.

This compound is primarily used in pharmaceutical research for its potential biological activity, particularly in the development of drugs targeting specific metabolic pathways. It may also find applications in organic synthesis and as a reagent in chemical research. Its unique structure makes it valuable for studying enzyme interactions and drug design. Search terms like 'purine derivative' and 'dioxaphosphinine compound' are relevant for its chemical classification.

The safety of this compound depends on its handling and exposure conditions. As a chemical compound, it may have potential toxicity if ingested or inhaled, so proper protective measures such as gloves and ventilation should be used. It is generally considered safe when handled according to standard chemical safety protocols. Safety data sheets and regulatory guidelines should be consulted for detailed information.

This compound should be stored in a cool, dry, and dark place to maintain its stability. It is recommended to keep it in a sealed container at a temperature below 25°C and avoid exposure to moisture and light. Proper storage conditions are crucial for preserving its chemical integrity and ensuring safe handling. Search terms like 'chemical storage' and 'compound stability' are important for related queries.